Influenza virus neuraminidase: Structure, antibodies, and inhibitors

The determination of the 3‐dimensional structure of the influenza virus neuraminidase in 1983 has served as a platform for understanding interactions between antibodies and protein antigens, for investigating antigenic variation in influenza viruses, and for devising new inhibitors of the enzyme. That work is reviewed here, together with more recent developments that have resulted in one of the inhibitors entering clinical trials as an anti‐influenza virus drug.

[1]  G. K. Hirst.  ADSORPTION OF INFLUENZA HEMAGGLUTININS AND VIRUS BY RED BLOOD CELLS , 1942, The Journal of experimental medicine.

[2]  F. Burnet,et al.  The receptor-destroying enzyme of V. cholerae. , 1947, The Australian journal of experimental biology and medical science.

[3]  J. F. Mccrea,et al.  Mucin as Substrate of Enzyme Action by Viruses of the Mumps Influenza Group , 1947, Nature.

[4]  Burnet Fm.  Mucins and Mucoids in relation to Influenza Virus Action. IV. Inhibition by Purified Mucoid of Infection and Haemagglutination with the Virus Strain WSE. , 1948 .

[5]  A. Gottschalk.  Neuraminidase; its substrate and mode of action. , 1958, Advances in enzymology and related subjects of biochemistry.

[6]  R. Sommerville,et al.  The inhibition of neuraminidase and antiviral action. , 1966, British journal of pharmacology and chemotherapy.

[7]  R. Webster,et al.  Antiviral Activity of Antiserum Specific for an Influenza Virus Neuraminidase , 1968, Journal of virology.

[8]  P. Meindl,et al.  Über 2-Deoxy-2,3-dehydro-sialinsäuren, 1. Mitt.: Synthese und Eigenschaften von 2-Deoxy-2,3-dehydro-N-acylneuraminsäuren und deren Methylestern , 1969 .

[9]  P. Palese,et al.  Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid. , 1974, Virology.

[10]  R. Compans,et al.  Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. , 1974, Virology.

[11]  R. Compans,et al.  Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. , 1976, The Journal of general virology.

[12]  W. G. Laver,et al.  Crystallization and peptide maps of neuraminidase "heads" from H2N2 and H3N2 influenza virus strains. , 1978, Virology.

[13]  P. Palese,et al.  Susceptibility of influenza A viruses to amantadine is influenced by the gene coding for M protein , 1978, Journal of virology.

[14]  R. Compans,et al.  Effect of cytochalasin B on the maturation of enveloped viruses , 1979, The Journal of experimental medicine.

[15]  A. Elbein,et al.  Sugar Residues on Protein , 1981 .

[16]  J. Paulson,et al.  Newcastle disease virus contains a linkage-specific glycoprotein sialidase. Application to the localization of sialic acid residues in N-linked oligosaccharides of alpha 1-acid glycoprotein. , 1982, The Journal of biological chemistry.

[17]  R. Rott,et al.  The specificity of viral sialidases. The use of oligosaccharide substrates to probe enzymic characteristics and strain-specific differences. , 2005, European journal of biochemistry.

[18]  R. Webster,et al.  Selection and analysis of antigenic variants of the neuraminidase of N2 influenza viruses with monoclonal antibodies. , 1982, Virology.

[19]  A. Helenius,et al.  Membrane fusion proteins of enveloped animal viruses , 1983, Quarterly Reviews of Biophysics.

[20]  A. Allen.  Mucus — a protective secretion of complexity , 1983 .

[21]  J. Paulson,et al.  The specificity of viral and bacterial sialidases for α(2–3)- and α(2–6)-linked sialic acids in glycoproteins , 1983 .

[22]  D. Jackson,et al.  Chemical and antigenic characterization of the carbohydrate side chains of an Asian (N2) influenza virus neuraminidase. , 1983, Virology.

[23]  J. N. Varghese,et al.  Structure of the catalytic and antigenic sites in influenza virus neuraminidase , 1983, Nature.

[24]  J. N. Varghese,et al.  Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution , 1983, Nature.

[25]  R. Compans,et al.  Effects of hexose starvation and the role of sialic acid in influenza virus release. , 1983, Virology.

[26]  M. Knossow,et al.  Three-dimensional structure of an antigenic mutant of the influenza virus haemagglutinin , 1984, Nature.

[27]  C. Chothia,et al.  Domain association in immunoglobulin molecules. The packing of variable domains. , 1985, Journal of molecular biology.

[28]  D. Wiley,et al.  Fusion mutants of the influenza virus hemagglutinin glycoprotein , 1985, Cell.

[29]  J. Skehel,et al.  The molecular basis of the specific anti‐influenza action of amantadine. , 1985, The EMBO journal.

[30]  P. Goodford.  A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.

[31]  J. N. Varghese,et al.  Three-dimensional structure of a complex of antibody with influenza virus neuraminidase , 1987, Nature.

[32]  G. Air,et al.  Antigenic structure and variation in an influenza virus N9 neuraminidase , 1987, Journal of virology.

[33]  R. Webster,et al.  Structure of an escape mutant of glycoprotein N2 neuraminidase of influenza virus A/Tokyo/3/67 at 3 A. , 1988, Journal of molecular biology.

[34]  S. Cusack,et al.  Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid , 1988, Nature.

[35]  P. Colman,et al.  Structure of antibody-antigen complexes: implications for immune recognition. , 1988, Advances in immunology.

[36]  P. Palese,et al.  Variation in Influenza Virus Genes , 1989 .

[37]  Don C. Wiley,et al.  Structure, Function, and Antigenicity of the Hemagglutinin of Influenza Virus , 1989 .

[38]  T. N. Bhat,et al.  Small rearrangements in structures of Fv and Fab fragments of antibody D 1.3 on antigen binding , 1990, Nature.

[39]  P. Colman,et al.  Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2.2 A resolution. , 1991, Journal of molecular biology.

[40]  César Milstein,et al.  Man-made antibodies , 1991, Nature.

[41]  A. van Donkelaar,et al.  Refined atomic structures of N9 subtype influenza virus neuraminidase and escape mutants. , 1992, Journal of molecular biology.

[42]  P. Kraulis.  A program to produce both detailed and schematic plots of protein structures , 1991 .

[43]  A. Edmundson,et al.  An autoantibody to single‐stranded DNA: Comparison of the three‐dimensional structures of the unliganded fab and a deoxynucleotide–fab complex , 1991, Proteins.

[44]  F. Hayden,et al.  Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine , 1991, Antimicrobial Agents and Chemotherapy.

[45]  Lawrence H. Pinto,et al.  Influenza virus M2 protein has ion channel activity , 1992, Cell.

[46]  P. Colman,et al.  The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor , 1992, Proteins.

[47]  R. Webster,et al.  Crystal structures of two mutant neuraminidase-antibody complexes with amino acid substitutions in the interface. , 1992, Journal of molecular biology.

[48]  W G Laver,et al.  Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex. , 1992, Journal of molecular biology.

[49]  S Cusack,et al.  The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid. , 1992, The EMBO journal.

[50]  M. von Itzstein,et al.  Evidence for a sialosyl cation transition-state complex in the reaction of sialidase from influenza virus. , 1992, European journal of biochemistry.

[51]  S. Crennell,et al.  Crystal structure of a bacterial sialidase (from Salmonella typhimurium LT2) shows the same fold as an influenza virus neuraminidase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[52]  S Cusack,et al.  Influenza B virus neuraminidase can synthesize its own inhibitor. , 1993, Structure.

[53]  D. M. Ryan,et al.  4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro , 1993, Antimicrobial Agents and Chemotherapy.

[54]  M. Lawrence,et al.  Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase , 1993, Journal of virology.

[55]  D. M. Ryan,et al.  Rational design of potent sialidase-based inhibitors of influenza virus replication , 1993, Nature.

[56]  R L Stanfield,et al.  Major antigen-induced domain rearrangements in an antibody. , 1993, Structure.

[57]  M. Lawrence,et al.  Shape complementarity at protein/protein interfaces. , 1993, Journal of molecular biology.

[58]  R. Webster,et al.  Recombinant antineuraminidase single chain antibody: Expression, characterization, and crystallization in complex with antigen , 1993, Proteins.

[59]  E Garman,et al.  Crystal structure of Vibrio cholerae neuraminidase reveals dual lectin-like domains in addition to the catalytic domain. , 1994, Structure.

[60]  E. Nice,et al.  Affinity ranking of influenza neuraminidase mutants with monoclonal antibodies using an optical biosensor. Comparison with ELISA and slot blot assays. , 1994, Journal of immunological methods.

[61]  W G Laver,et al.  The structure of a complex between the NC10 antibody and influenza virus neuraminidase and comparison with the overlapping binding site of the NC41 antibody. , 1994, Structure.

[62]  R. Webster,et al.  Recombinant anti-sialidase single-chain variable fragment antibody. Characterization, formation of dimer and higher-molecular-mass multimers and the solution of the crystal structure of the single-chain variable fragment/sialidase complex. , 1994, European journal of biochemistry.

[63]  M. von Itzstein,et al.  Slow-binding inhibition of sialidase from influenza virus. , 1994, Biochemistry and molecular biology international.